In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

00:24 EDT 20th October 2014 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 4,000+

Tuesday 14th October 2014

RPS gets $28 million in debt financing

RPS Diagnostics announced the closing of $28 million of non-dilutive debt financing with OrbiMed. This and other preceding financing allow RPS significant flexibility as it continues to grow and advance toward profitability. The combination of RPS’s strong intellectual property (IP) and unique technology platforms facilitates the development of unique and easy-to-use tests that target critical m...

Genomics England Names QIAGEN Bioinformatics One of the UK100K Project Assessment Winners

Ambitious project to sequence and interpret 100,000 whole genomes from NHS patients in the United Kingdom names key technology collaborators QIAGEN Bioinformatics to provide project researchers access to Ingenuity® Variant Analysis™ to enable the rapid identification of disease causal variants from NGS data ...

NantOmics Selected by Genomics England to Move to Next Stage of 100,000 Genomes Project for Patients with Cancer

The Nantworks Company Acknowledged As Potential Provider For Variant Annotation And Clinical Interpretation Element Of 100,000 Genome Project Dr. Patrick Soon-Shiong, Chairman and CEO of NantOmics, a member of the Nant family of companies, announced today that the company had been advanced to the next phase of Genomics England’s annotation assessment ...

Diagnostics and Therapeutics for HIV: Global Markets

LONDON, Oct. 14, 2014 /PRNewswire/ -- STUDY GOALS AND OBJECTIVESThe aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for products used in the treatment, testing and prophylaxis of HIV/AIDS. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2018; t...

Pharmaceutical Sales Highlight A Strong Third Quarter For Johnson & Johnson

By David Schauber, Jr.:Today, Johnson & Johnson (NYSE:JNJ) reported earnings for their third quarter and offered guidance for the rest of 2014. Let's take a look and see how they did, and what we can expect going forward. The Results For the third quarter of 2014, Johnson & Johnson reported sales of $18.5B, representing a 5.1% increase versus what was accomplished during the same period ...

Medtronic Begins Pivotal Study of First Predictive Low Glucose Management Technology for People with Diabetes

In-Clinic Study Marks Critical Step Toward an Artificial Pancreas and Key Milestone Toward U.S. Commercialization MINNEAPOLIS - October 14, 2014 - Medtronic, Inc. (NYSE:MDT) today announced that the first patients have been enrolled in an investigational device exemption (IDE) study of its breakthrough Predictive Low Glucose Management (PLGM) technology, marking a critical step toward deve...

InSphero Wins ACES Award as Top European Academic Enterprise in Life Sciences

Second honor in three weeks continues momentum for leading supplier of 3D microtissues for in vitro toxicity and efficacy testing. Schlieren, Switzerland (PRWEB) October 14, 2014 InSphero AG, the leading provider of 3D cell culture technology, assay-ready 3D microtissues and 3D-focused contract research services, was recognized Tuesday as winner of the 2014 ACES Life Sciences Award. The pan-Euro...

NanoLogix Technology Being Configured For Rapid Ebola Virus Detection

Seeks Corporate Project Partner For Ebola Detection Kits NanoLogix Inc. (NNLX), an innovative biotechnology company in Northeastern Ohio announces that it is configuring its N-Assay Rapid diagnostic kits for both Ebola Virus and Enterovirus detection and identificati

AmericanBio expands product offerings, introduces exclusive CLIA Grade product line.

Introducing the Next Generation of Reproducible Reactions. Natick, MA. (PRWEB) October 14, 2014 AmericanBio, a premier provider of custom reagent manufacturing services, unveils their clinical laboratory solution “CLIA Grade” products. CLIA labs shared their needs and concerns with AmericanBio, which included inconsistent analytical results, poor functional performance results and ongoing reg...

sphingotec and GeneNews Limited/Innovative Diagnostics Laboratory (IDL) Sign a Licensing and Cooperation Agreement for the U.S. Market

GeneNews/IDL will be first U.S. laboratory to offer sphingotec’s innovative breast cancer risk tests sphingotec GmbH, headquartered in Hennigsdorf, Germany with U.S. operations in Cambridge, Massachusetts, today announced that it has out-licensed two of its biomarker assays—sphingotest® pro-NT and sphingotest® pro-ENK—to GeneNews Limited...

Accelerate Diagnostics: Mistakenly Rewarded And Destined To Crash?

By The Street Sweeper:Accelerate Diagnostics (Nasdaq: AXDX) might need to credit a "false positive" for making its stock price look so much healthier these days. Mistaken by some as a promising Ebola play, AXDX has skyrocketed in value over the course of the past few weeks - its share price, up almost 70%, escalating right along with fears of that horrific virus - even though its experimental devi...

Clinical Laboratory Services Market By Test (Human & Tumor Genetics, Clinical Chemistry), By Service Provider (Hospitals) Is Expected To Reach USD 261.42 Billion By 2020

Market Size - $174.14 billion in 2013, Market Growth - CAGR of 6.0%, Market Trends - Growing demand for early disease diagnosis - Latest report by Grand View Research. View full report with TOC - http://www.grandviewresearch.com/industry-analysis/clinical-laboratory-services-market. San Francisco, California (PRWEB) October 14, 2014 Global clinical laboratory services market is expected to reach ...

NextCODE Takes Top Marks in Genomics England Analysis and Interpretation 'Bake Off'

CAMBRIDGE, Mass., Oct. 14, 2014 /PRNewswire/ -- NextCODE Health, which enables clinicians and scientists to use the full power of the whole genome in real time, today announced that Genomics England (GeL) has invited NextCODE to take part in the analysis of forthcoming whole-genome sequence data across GeL's focus areas in rare diseases and cancer. GeL is expected to begin large-scale sequenc...

Healthcare Executive Greg Roth Joins One Call Care Management’s Board of Directors

Former TeamHealth and HCA Executive Joins One Call’s Board One Call Care Management (One Call), the nation’s leading provider of specialized services that add value throughout the continuum of workers’ compensation care, has named healthcare executive Greg Roth to its Board of Directors. “Greg’s experience as a leader and inno...

NextCODE Takes Top Marks in Genomics England Analysis and Interpretation ‘Bake Off’

Proven population-scale platform delivers best results in rare disease and cancer clinical interpretation, as well as secondary analysis and variant refinement CAMBRIDGE, Massachusetts, 14 October 2014 – NextCODE Health, which enables clinicians and scientists to use the full power of the whole genome in real time, today announced that Genomics England (GeL) has invited NextCODE to take part in ...

Novel Protein May Hold Promise for Enhancing Artificial Tear Formulations

PLYMOUTH, Minn., Oct. 14, 2014 /PRNewswire/ -- SilkTears, LLC, a privately held, research-based and product-driven biotechnology company, announced today that advances in protein-based excipient technology may allow for the development of artificial tear products that will more closely represent certain characteristics of the natural makeup of the tear film, and may help the significant popul...

Sanovas Awarded Seminal Patent for Novel Radiation Oncology Drug/Device Platform

SAN RAFAEL, Calif., Oct. 14, 2014 /PRNewswire/ -- Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation microinvasive diagnostics, devices and drug delivery technologies, announced today that US Patent No. 8,834,544 has issued to the Company. Photo - http://photos.prnewswire.com/prnh/20141013/151744       ...

Mindray to Report Third Quarter 2014 Financial Results on Nov 3, 2014

SHENZHEN, China, Oct. 14, 2014 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the third quarter ended Sept 30, 2014 after the U.S. market closes on Nov 3, 2014. Mindray's management will hold an earnings conference call at 8:00...

The Genome Institute at Washington University Receives Irys System from BioNano Genomics to Advance Research for Genome Reference Consortium

SAN DIEGO and ST. LOUIS, Oct. 14, 2014 /PRNewswire/ -- BioNano Genomics announced today the purchase of an Irys™ System by The Genome Institute at Washington University in St. Louis to assist, among other projects, in improving the quality of the human reference genome for the Genome Reference Consortium (GRC). The goal of the GRC is to ensure that the human, mouse and zebrafish re...

Johnson & Johnson Reports 2014 Third-Quarter Results:

NEW BRUNSWICK, N.J., Oct. 14, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $18.5 billion for the third quarter of 2014, an increase of 5.1% as compared to the third quarter of 2013. Operational results increased 5.8% and the negative impact of currency was 0.7%. Domestic sales increased 11.6%. International sales decreased 0.3%, reflecting operational growth...

Ophthalmology device market poised for growth, report says

A Markets & Markets report predicts that the market for ophthalmology devices used for diagnostics, monitoring, vision care a -More- 

Cerilliant Introduces Stable-Labeled Certified Reference Materials of Kratom Alkaloids

ST. LOUIS, Oct. 14, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) is pleased to announce that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first stable-labeled internal standards of the kratom alkaloids mitragynine and 7-hydroxymitragynine. These new solution Certified Reference Materials (CRMs) offer testing laboratorie...

Rubicon Genomics Adds New Global Distributors And Hires Experienced Product Development Executive

ANN ARBOR, Mich., Oct. 14, 2014 /PRNewswire/ -- Rubicon Genomics, Inc., today announced that it has signed agreements with new distributors in Europe, North Africa and Asia to further expand the availability of its DNA library preparation products for arrays and Illumina® next-generation sequencing (NGS) platforms, including ThruPLEX® DNA-seq, PicoPLEXTM DNA-seq, and PicoPLEX WGA Ki...

Boston Strategics Corporation Announces Key Agreement in Translational Oncology with Molecular Response

BOSTON, Oct. 14, 2014 /PRNewswire/ -- Boston Strategics Corporation (BSC), an integrated clinical-stage drug research and development (R&D) company, Boston, MA, today announced that it has entered into an agreement with Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics. In collab...

Aethlon Medical Announces First Treatment of an Ebola Patient

SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD), announced today the first use of Hemopurifier® therapy on a patient infected with Ebola virus.  The treatment was administered to a Ugandan doctor at the Frankfurt University Hospital in Germany.  The patient, who is also a World Health Organization (WHO) worker, contracted the virus in Sierra Leone....


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks